SecBot SecBot
SECBOTREPLAY Home › Report › VTGN

VTGN · Vistagen Therapeutics appointed Douglas J

Vistagen Therapeutics, Inc. · 8-K filed Jul 31, 2026 at 08:48 ET

At the news

NEUTRALIMPACT 2/10

8-K filed Jul 31, 2026 at 08:48 ET

Vistagen Therapeutics appointed Douglas J. Williamson, M.D. to its Board of Directors effective July 29, 2026. Dr. Williamson received stock options to purchase 40,826 shares at $0.2433 per share, vesting over three years. This is a routine board appointment with no material financial or operational impact.

  • Douglas J. Williamson, M.D. appointed to the Board of Directors on July 29, 2026.
  • Received options to purchase 40,826 shares of common stock at an exercise price of $0.2433 per share (closing price on appointment date).
  • Options vest in equal annual installments over three years, fully vested on the three-year anniversary.
  • Dr. Williamson also entitled to annual cash compensation and equity awards under the Director Compensation Plan.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access